Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11680097 Antibodies against canine PD-1

Overview Structured Data Issues Contributors Activity

All edits

Edits on 21 Jun, 2023

"Created via: Entity Importer"

Golden AI

created this topic on 21 Jun, 2023

Edits made to:

Infobox (+26 properties)

Article (+247 characters)

‌

US Patent 11680097 Antibodies against canine PD-1

Article

The present invention discloses antibodies to canine PD-1 that have specific sequences and a high binding affinity for canine PD-1. The invention also discloses the use of the antibodies of the present invention in the treatment of cancer in dogs.

Infobox

Is a

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

116800970

Date of Patent

June 20, 2023

Patent Application Number

168935290

Date Filed

June 5, 2020

Patent Citations

‌

US Patent 7101550 PD-1, a receptor for B7-4, and uses therefor

‌

US Patent 7105328 Methods for screening for compounds that modulate pd-1 signaling

‌

US Patent 7261890 Methods for using canine immunoglobulin variable domains and caninized antibodies

‌

US Patent 7432059 Methods of identifying compounds that upmodulate T cell activation in the presence of a PD-1 mediated signal

‌

US Patent 7595048 Method for treatment of cancer by inhibiting the immunosuppressive signal induced by PD-1

‌

US Patent 7635757 B7-4 Antibodies and uses therefor

‌

US Patent 7700301 Methods for screening for compounds that modulate PD-1 signaling

‌

US Patent 7709214 Methods for upregulating an immune response with agents that inhibit the intereaction between PD-L2 and PD-1

‌

US Patent 7722868 Agents that modulate the interaction of B7-1 polypeptide with PD-L1 and methods of use thereof

‌

US Patent 7807158 Antibodies against IL-13 receptor alpha1 and uses thereof

‌

US Patent 8008449 Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics

‌

US Patent 8337842 Monoclonal antibodies

‌

US Patent 8569460 Antibody constant domain regions and uses thereof

‌

US Patent 8652470 Monoclonal antibodies directed to CD52

‌

US Patent 8735553 Anti-PD1 antibodies and their use as therapeutics and diagnostics

‌

US Patent 9580496 Therapeutic canine immunoglobulins and methods of using same

‌

US Patent 10280223 Anti-canine PD-1 antibody or anti-canine PD-L1 antibody

Patent Primary Examiner

‌

Nelson B Moseley, II

Find more entities like US Patent 11680097 Antibodies against canine PD-1

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API